Australia, Nov. 4 -- NeuroQure Inc., owns the trademark (2577202) for 'NEUROQURE ASD INSIGHT' till May 5, 2035.
Status: protected:
Registered/protected
Classes: 5 [Diagnostic testing kits comprised of medical diagnostic reagents for testing skin cells to identify genetic markers; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing neurological and developmental disorders.], 42 [Laboratory research and analysis services in the field of genetics; laboratory analysis for fragile X syndrome, autism, and other genetic conditions; providing medical laboratory services in the field of genetic testing; medical laboratory services for diagnosing genetic disorders; research and development of new products for medical diagnostic monitoring and testing; providing medical and scientific research information via the internet.] and 44 [Medical diagnostic testing, monitoring and reporting services; health care services, namely, health assessment services in the nature of behavioral assessment, behavior analysis therapy, medical care, and treatment of behavioral and developmental disorders, including autism, developmental delays, and fragile X syndrome; medical consultation services in the fields of laboratory testing, and diagnostics; genetic testing for medical purposes.]
Type of Mark: Word
Date of Acceptance: Aug. 25
Registration Advertised: Nov. 3
For further details contact Ashurst Australia and KNOBBE MARTENS OLSON & BEAR LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2577202.
Disclaimer: Curated by HT Syndication.
